Johnson & Johnson and Janssen Biotech settle Remicade class action lawsuit after 6 years

The lawsuit alleged Johnson& Johnson acted improperly to block competition for its blockbuster drug Remicade.

Source: bizjournals.com Health Care:Physician Practices headlines - March 20, 2023 Category: American Health Authors: John George Source Type: news